| Primary |
| Bladder Cancer |
17.5% |
| Anal Cancer |
11.4% |
| Hepatic Neoplasm Malignant |
8.1% |
| Penis Carcinoma |
8.1% |
| Trabeculectomy |
6.1% |
| Adenocarcinoma Pancreas |
5.9% |
| Appendix Cancer |
4.6% |
| Peritoneal Carcinoma Metastatic |
4.4% |
| Bladder Transitional Cell Carcinoma |
4.2% |
| Squamous Cell Carcinoma |
4.2% |
| Bile Duct Cancer |
3.7% |
| Product Used For Unknown Indication |
3.5% |
| Metastases To Liver |
2.8% |
| Colorectal Cancer |
2.6% |
| Breast Cancer |
2.4% |
| Hepatic Cancer Metastatic |
2.2% |
| Ovarian Cancer |
2.2% |
| Gastric Cancer |
2.0% |
| Hepatic Neoplasm Malignant Recurrent |
2.0% |
| Transitional Cell Carcinoma |
2.0% |
|
| Off Label Use |
18.2% |
| Rash |
7.4% |
| Interstitial Lung Disease |
6.8% |
| Sepsis |
6.8% |
| Bladder Perforation |
6.3% |
| Endophthalmitis |
5.1% |
| Eosinophilic Cystitis |
5.1% |
| Treatment Related Secondary Malignancy |
4.5% |
| Corneal Epithelium Defect |
4.0% |
| Gastric Perforation |
4.0% |
| Haemolytic Uraemic Syndrome |
4.0% |
| Thrombocytopenia |
4.0% |
| Pulmonary Fibrosis |
3.4% |
| Respiratory Failure |
3.4% |
| Cystitis |
2.8% |
| Iridocyclitis |
2.8% |
| Liver Abscess |
2.8% |
| Postoperative Wound Complication |
2.8% |
| Pruritus |
2.8% |
| Thrombotic Thrombocytopenic Purpura |
2.8% |
|
| Secondary |
| Breast Cancer |
18.1% |
| Hodgkin's Disease |
9.7% |
| Lung Neoplasm Malignant |
9.7% |
| Non-hodgkin's Lymphoma |
9.5% |
| Colorectal Cancer Metastatic |
8.6% |
| Pancreatic Carcinoma Non-resectable |
6.6% |
| Breast Cancer Metastatic |
5.9% |
| Hepatic Neoplasm Malignant |
5.0% |
| Drug Use For Unknown Indication |
4.7% |
| Anal Cancer |
3.4% |
| Metastases To Liver |
2.5% |
| Peritoneal Mesothelioma Malignant |
2.3% |
| Pseudomyxoma Peritonei |
2.3% |
| Anal Squamous Cell Carcinoma |
2.1% |
| Prophylaxis |
2.0% |
| Metastases To Peritoneum |
1.7% |
| Gastric Cancer |
1.6% |
| Appendix Cancer |
1.5% |
| Colon Cancer |
1.5% |
| Non-small Cell Lung Cancer |
1.5% |
|
| Thrombocytopenia |
14.2% |
| Off Label Use |
6.8% |
| Rash |
6.8% |
| Vomiting |
6.8% |
| White Blood Cell Count Decreased |
6.3% |
| Incorrect Route Of Drug Administration |
5.7% |
| Gastric Perforation |
4.5% |
| Neoplasm Recurrence |
4.5% |
| Renal Failure Acute |
4.5% |
| Haemolytic Uraemic Syndrome |
4.0% |
| Hepatic Failure |
4.0% |
| Proteinuria |
4.0% |
| Stomatitis |
4.0% |
| Malignant Hypertension |
3.4% |
| Pancytopenia |
3.4% |
| Postoperative Wound Complication |
3.4% |
| Pulmonary Infarction |
3.4% |
| Respiratory Arrest |
3.4% |
| Respiratory Distress |
3.4% |
| Sepsis |
3.4% |
|
| Concomitant |
| Breast Cancer |
14.0% |
| Anal Cancer |
7.0% |
| Colon Cancer |
7.0% |
| Gastric Cancer |
6.8% |
| Breast Cancer Metastatic |
6.5% |
| Product Used For Unknown Indication |
6.5% |
| Metastases To Bone |
6.1% |
| Metastases To Liver |
5.4% |
| Prophylaxis |
5.4% |
| Hiv Infection |
5.0% |
| Behcet's Syndrome |
4.5% |
| Bladder Cancer |
3.8% |
| Hepatic Neoplasm Malignant |
3.6% |
| Metastases To Lung |
3.4% |
| Colon Cancer Metastatic |
2.9% |
| Drug Use For Unknown Indication |
2.9% |
| Cancer Pain |
2.7% |
| Trabeculectomy |
2.3% |
| Colorectal Cancer Metastatic |
2.0% |
| Hypertension |
2.0% |
|
| Hepatic Steatosis |
22.6% |
| Febrile Neutropenia |
9.4% |
| Disease Progression |
7.5% |
| Vomiting |
7.5% |
| White Blood Cell Count Decreased |
6.6% |
| Thrombocytopenia |
4.7% |
| White Blood Cell Count Increased |
4.7% |
| Osteonecrosis Of Jaw |
3.8% |
| Vasculitis |
3.8% |
| Acute Myeloid Leukaemia |
2.8% |
| Anaphylactic Shock |
2.8% |
| Arterial Spasm |
2.8% |
| Bladder Cancer |
2.8% |
| Bovine Tuberculosis |
2.8% |
| Colitis |
2.8% |
| Gastric Cancer |
2.8% |
| Rash |
2.8% |
| Tooth Extraction |
2.8% |
| Anaemia |
1.9% |
| Blood Pressure Increased |
1.9% |
|
